2-chloro-5-(1H-1,2,3,4-tetrazol-5-yl)pyridine, 98%, 1g

Ácido fenilacetilenocarboxílico, mínimo 98%, para síntesis, 5 g, envase de plástico.

4-Methylbenzamidine hydrochloride, 97.0%, 10g

3-Ethoxy-2-nitropyridine>98.0%(GC)5g

[2,2'-Bithiophen]-5-ylboronic acid, 95.0%, 5g

Methyl 4-bromo-3-methyl-2-nitrobenzoate, 97%, 1g

2-Bromo-6-morpholinopyridine, 95.0%, 5g

2-Hydroxy-4-methylthiazole-5-carboxylic acid, 95.0%, 10g

5-Bromo-1H-pyrazolo[3,4-b]pyridin-3-amine, 97%, 1g

2,6-Dibromo-3-nitropyridine, 97.0%, 25g

4-hydrazino-1-methylpiperidine dihydrochloride, 95.0%, 1g

Methyl 1-(3-bromo-6-chloropyridin-2-yl)cyclopropane-1-carboxylate, 1g

3,5-Dibromo-1-methylpyrazin-2(1H)-one, 95.0%, 10g